Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HIV & AIDS Health Center

Font Size

Gene Silencing May Stop AIDS Virus

Study Shows New Technique Has Potential as AIDS Therapy


Fischl has seen a lot of promising AIDS therapies come and go, but she finds the siRNA approach "intriguing" and would like to see it explored further.

One of the researchers doing this exploration is Ramesh K. Akkina, PhD, professor of microbiology, immunology, and pathology at Colorado State University, Fort Collins.

"The Shankar lab's finding is certainly an exciting development," Akkina tells WebMD. "This siRNA is a very interesting molecule that is actually programming cells to deal with the virus."

Akkina notes that the Shankar/Kumar team is using direct injections of siRNA constructs, an approach to gene therapy that would require repeat administrations. Another approach uses a genetically engineered virus that infects blood-forming stem cells and becomes a permanent part of their genome. When these stem cells become T cells, they produce siRNA and are immune to HIV infection.

"In the approach with the stem-cell gene-therapy approach, we are programming blood-forming stem cells with anti-HIV siRNA so that the stem cells are viable lifelong in the individual," Akkina says. "The virus-resisting cells are produced on a daily basis."

Sponsored by Benitec, the firm developing this approach, a phase I safety study of virus-delivered siRNA is under way at City of Hope Medical Center in Duarte, Calif.

Kumar says her team's approach would avoid the pitfall of having a foreign virus integrate into the human genome.

Both approaches hold promise for reaching the so-called "resting" T-cells in which HIV is able to hide from current AIDS therapies. Reaching these HIV reservoirs is the key to eliminating HIV from the body.

"These approaches could be used to purge the latently infected cells," Akkina says.

Kumar agrees.

"The advantage of siRNA is that you can deliver it into resting T cells," she says. "So if these siRNA are present when the cell becomes activated and starts to produce HIV, you have siRNA there ready to combat it."

Kumar and colleagues report their findings in the Aug. 22 issue of the journal Cell. Kumar, an instructor at Harvard Medical School while working in the Shankar lab, is now an assistant professor at Yale University.

1 | 2

Today on WebMD

How much do you know?
contemplative man
What to do now.
Should you be tested?
HIV under microscope
What does it mean?
HIV AIDS Screening
man opening condom wrapper
HIV AIDS Treatment
Discrimination Stigma
Treatment Side Effects
grilled chicken and vegetables
obese man standing on scale
cold sore